Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Shu-Meng Cheng, Guang-Yuan Mar, Shih-Chung Huang, Chung-Sen Chen, Chih-Min Hsieh, Lien-Chi Huang & Kwo-Chang Ueng. (2012) Post-marketing surveillance study of valsartan/amlodipine combination in Taiwanese hypertensive patients. Blood Pressure 21:sup1, pages 11-19.
Read now
Read now
Christoph Axthelm, Christian Sieder, Franziska Meister & Edelgard Kaiser. (2012) Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg. Current Medical Research and Opinion 28:1, pages 69-78.
Read now
Read now
Roberto Fogari & Annalisa Zoppi. (2011) A drug safety evaluation of valsartan. Expert Opinion on Drug Safety 10:2, pages 295-303.
Read now
Read now
Joel M. Neutel. (2011) Long-Term Blood Pressure Control: What Can We Do?. Postgraduate Medicine 123:1, pages 88-93.
Read now
Read now
Johannes Schweizer, Hans-Joachim Ulmer, Henning Benduhn & Sven Klebs. (2011) Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (±amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg. Current Medical Research and Opinion 27:1, pages 131-140.
Read now
Read now
David T Nash & Michael S McNamara. (2009) Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility. Integrated Blood Pressure Control 2, pages 39-54.
Read now
Read now
Barrios Vivencio, Braun Norbert, Braun Norbert & Klebs Sven. (2009) Comment and reply on: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination. Current Medical Research and Opinion 25:9, pages 2267-2269.
Read now
Read now
Articles from other publishers (7)
Gianfranco Parati, Sverre Kjeldsen, Antonio CocaWilliam C. Cushman & Jiguang Wang. (2021) Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension. Hypertension 77:2, pages 692-705.
Crossref
Crossref
Muhammad Ali Sheraz, Syed Furqan Ahsan, Marium Fatima Khan, Sofia Ahmed & Iqbal Ahmad. (2016) Formulations of Amlodipine: A Review. Journal of Pharmaceutics 2016, pages 1-11.
Crossref
Crossref
Yuri Karpov, Neelesh Dongre, Alexey Vigdorchik & Krisada Sastravaha. (2012) Amlodipine/Valsartan Single-Pill Combination: A Prospective, Observational Evaluation of the Real-Life Safety and Effectiveness in the Routine Treatment of Hypertension. Advances in Therapy 29:2, pages 134-147.
Crossref
Crossref
Raymond V. Oliva & George L. Bakris. 2012. The Kidney in Heart Failure. The Kidney in Heart Failure
169
182
.
Raymond V. Oliva & George L. Bakris. 2012. Managing the Kidney when the Heart is Failing. Managing the Kidney when the Heart is Failing
59
72
.
Irina E. Chazova, Neelesh Dongre & Alexey V. Vigdorchik. (2011) Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension. Advances in Therapy 28:2, pages 134-149.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:9.
Crossref
Crossref